Back to All Events

Sci & Risk Based Stab Practices in Pharma Devel. Part III: Leveraging Knowledge to Design Studies

Sci & Risk Based Stab Practices in Pharma Devel. Part III: Leveraging Knowledge to Design Studies

February 17, 2022

Webinar

Location: Virtual

Venue: GoToWebinar

Register for this Event

Science & Risk Based Stability Practices in Pharmaceutical Development Part III: Leveraging Knowledge to Design Appropriate Stability Studies

Thu, Feb 17, 2022 11:00 AM - 12:00 PM EST

Presented by the Science & Risk Based Stability Working Group
Sponsored by the Analytical Leadership Group

Speakers

Stability data that is collected throughout development should help inform downstream decisions and additional stability study designs to ensure the appropriate attributes are being investigated. This webinar will further enhance the stability life cycle concept throughout development by illustrating how data from early development and clinical stability studies can be leveraged to design appropriate late stage and/or ICH stability studies.

The following learning points will be discussed:

This webinar is open to the general public. Membership in the IQ Consortium is not required for registration.